Research & Publications
Elias Lolis received a BA degree in Chemistry at Columbia College and PhD in Chemistry from MIT training in structural biology. His postdoctoral training was in the Laboratory of Medical Biochemistry at Rockefeller University studying the functional interactions between advanced glycation endproducts (AGEs) and the immune system. He currently studies the mechanism of chemokines, the macrophage migration inhibitory factor (MIF) family of proteins, and their receptors in disease (cancer, inflammation, and infection) using structural biology, Crispr/Cas9 in mouse models of disease, and high throughput screening of small molecules as well as designing biotherapeutics. He received a Pharmaceutical Manufacturers Association Faculty Development Award in Basic Pharmacology, the Donaghue Young Investigator Award, and the GlaxoWellcome Award in Drug Discovery. He is the founder and co-founder of the Yale Macromolecular X-ray Facility and Yale Keck Bioinformatics Resource, respectively. More than 25 postdoctoral associates, seven PhD students, two postgrads, seven Yale undergraduates, ten under-represented minority summer students (BioStep and PREP), and 22 undergraduates and high school students from other schools were trained by him or his senior staff. He has been involved in the recruitment of under-represented minorities ever since he was an Assistant Professor traveling to various schools and conferences and, more recently, was a member of various committees of the 2020-21 and 2021-22 Intersections Science Fellows Symposium. He also serves as the Faculty Director of the Office for Postdoctoral Affairs for the University, his department's Director of Graduate Studies, and his department's Diversity, Equity, and Inclusion Committee, and mentors students and postdocs in his research lab.
Education & Training
- PostdocRockefeller University (1991)
- PhDMassachusetts Institute of Technology, Biochemistry/Chemistry (1989)
- BAColumbia College (1984)